Helius Medical Technologies (NASDAQ:HSDT) Issues Earnings Results, Misses Expectations By $0.14 EPS

Helius Medical Technologies (NASDAQ:HSDT) issued its quarterly earnings data on Monday. The company reported ($0.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.14), Zacks reports. The business had revenue of $0.18 million during the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. During the same quarter last year, the firm posted ($3.00) earnings per share.

Helius Medical Technologies Stock Performance

NASDAQ HSDT traded down $0.07 during trading hours on Wednesday, reaching $0.68. The company’s stock had a trading volume of 35,811 shares, compared to its average volume of 326,800. Helius Medical Technologies has a fifty-two week low of $0.65 and a fifty-two week high of $13.43. The stock has a market cap of $2.02 million, a PE ratio of -0.06 and a beta of 1.60. The company’s 50-day moving average is $0.91 and its two-hundred day moving average is $3.33.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.